Abbvie

It’ll be here sooner than you think…

It’ll pay to think like a contrarian in 2020, and this 6.4%-yielding dividend payer is proof…

Aaron Task examines how the coronavirus outbreak could affect global markets.

For income investors, turning to options and increasing trading frequency with the help of experts can significantly boost returns.

This biopharma giant may be garnering negative press lately, but its dividend safety tells a different story.

Remaining objective while investing isn’t just responsible… it’s necessary.